W Matthew Foehr

Affiliations

  • at Viking Therapeutics Inc. (VKTX), 2025-04-14
  • President And Ceo at Omniab Inc. (OABI), 2025-04-08
  • Clo & Secretary at Omniab Operations Inc. (NONE), 2022-11-04
  • Other at Ligand Pharmaceuticals Inc (LGND), 2022-11-04
  • Director at Ritter Pharmaceuticals Inc (RTTR), 2020-04-23
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
OABI $4.42 240,000 $1,059,840.00 3,536,665 2024-05-24 Filing
OABI $5.19 225,000 $1,167,750.00 2,908,803 2024-03-22 Filing
OABI $5.05 200,000 $1,010,000.00 2,645,442 2023-12-12 Filing
OABI $4.27 95,000 $405,517.00 2,427,919 2023-11-10 Filing
OABI $5.48 45,000 $246,600.00 2,332,919 2023-08-14 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
OABI $2.00 19,382 $38,764.00 3,796,236 2025-04-07 Filing
OABI $3.67 19,522 $71,645.74 3,779,160 2025-02-19 Filing
OABI $3.68 13,964 $51,387.52 3,798,682 2025-02-18 Filing
OABI $3.24 41,811 $135,467.64 3,749,639 2025-01-21 Filing
OABI $4.13 13,634 $56,308.42 3,714,447 2024-12-09 Filing